Kobra Velaei

1.1k total citations · 1 hit paper
20 papers, 827 citations indexed

About

Kobra Velaei is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kobra Velaei has authored 20 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Kobra Velaei's work include RNA Interference and Gene Delivery (4 papers), Immune Cell Function and Interaction (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Kobra Velaei is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Immune Cell Function and Interaction (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Kobra Velaei collaborates with scholars based in Iran, Vietnam and Spain. Kobra Velaei's co-authors include Bahman Yousefi, Maryam Ezzati, Amin Safa, Nasser Samadi, Jafar Soleimani Rad, Hojjatollah Nozad Charoudeh, Roya Salehi, Amir Mehdizadeh, Masoud Darabi and Abbas Pirpour Tazehkand and has published in prestigious journals such as Sensors and Actuators B Chemical, Life Sciences and Journal of Cellular Physiology.

In The Last Decade

Kobra Velaei

19 papers receiving 816 citations

Hit Papers

A review on anti-cancer properties of Quercetin in breast... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kobra Velaei Iran 14 400 202 159 125 88 20 827
Jian-Ge Qiu China 16 435 1.1× 221 1.1× 133 0.8× 77 0.6× 105 1.2× 29 790
Yuxin Li China 22 643 1.6× 151 0.7× 163 1.0× 143 1.1× 52 0.6× 68 1.2k
Ayşegül Varol Germany 4 491 1.2× 114 0.6× 162 1.0× 76 0.6× 79 0.9× 7 910
Yunyan Zhang China 16 414 1.0× 104 0.5× 155 1.0× 65 0.5× 91 1.0× 44 951
Rhonda J. Rosengren New Zealand 16 470 1.2× 187 0.9× 139 0.9× 155 1.2× 91 1.0× 32 943
Maria Rita Emma Italy 18 456 1.1× 116 0.6× 152 1.0× 80 0.6× 69 0.8× 25 846
Giuseppa Augello Italy 21 529 1.3× 165 0.8× 192 1.2× 107 0.9× 84 1.0× 35 1.0k
Lijun Zhang China 22 722 1.8× 194 1.0× 178 1.1× 129 1.0× 83 0.9× 63 1.4k
Anil Kumar Badana India 12 591 1.5× 114 0.6× 268 1.7× 90 0.7× 84 1.0× 15 998
Nina Xue China 18 508 1.3× 143 0.7× 94 0.6× 154 1.2× 51 0.6× 46 896

Countries citing papers authored by Kobra Velaei

Since Specialization
Citations

This map shows the geographic impact of Kobra Velaei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kobra Velaei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kobra Velaei more than expected).

Fields of papers citing papers by Kobra Velaei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kobra Velaei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kobra Velaei. The network helps show where Kobra Velaei may publish in the future.

Co-authorship network of co-authors of Kobra Velaei

This figure shows the co-authorship network connecting the top 25 collaborators of Kobra Velaei. A scholar is included among the top collaborators of Kobra Velaei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kobra Velaei. Kobra Velaei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jalilzadeh, Nazila, et al.. (2023). Studying Luminal, A and B subtypes of the breast cancer under paracrine secretion of fibroblasts. Bioimpacts. 14(3). 27591–27591. 1 indexed citations
2.
Jalilzadeh, Nazila, et al.. (2022). Understanding and targeting anoikis in metastasis for cancer therapies. Cell Biology International. 47(4). 683–698. 39 indexed citations
3.
Valilo, Mohammad, et al.. (2022). The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy. Breast Cancer. 29(5). 778–789. 22 indexed citations
4.
Velaei, Kobra, et al.. (2022). RNA interference: Promising approach for breast cancer diagnosis and treatment. Cell Biology International. 47(5). 833–847. 11 indexed citations
5.
Velaei, Kobra, et al.. (2022). Anoikis in cancer: The role of lipid signaling. Cell Biology International. 46(11). 1717–1728. 34 indexed citations
6.
Velaei, Kobra, et al.. (2022). Porcn as a novel therapeutic target in cancer therapy:  A review. Cell Biology International. 46(12). 1979–1991. 3 indexed citations
7.
Ezzati, Maryam, et al.. (2021). Melatonin and its mechanism of action in the female reproductive system and related malignancies. Molecular and Cellular Biochemistry. 476(8). 3177–3190. 10 indexed citations
8.
Jalilzadeh, Nazila, et al.. (2021). Understanding breast cancer heterogeneity through non-genetic heterogeneity. Breast Cancer. 28(4). 777–791. 7 indexed citations
9.
Velaei, Kobra, Ali Rafat, Hamid Tayefi Nasrabadi, et al.. (2021). The role of KIR positive NK cells in diseases and its importance in clinical intervention. International Immunopharmacology. 92. 107361–107361. 24 indexed citations
10.
Talebi, Mehdi, et al.. (2021). Platelet-Rich and Platelet-Poor Plasma Might Play Supportive Roles in Cancer Cell Culture: A Replacement for Fetal Bovine Serum?. Anti-Cancer Agents in Medicinal Chemistry. 21(16). 2236–2242. 2 indexed citations
11.
Tazehkand, Abbas Pirpour, Roya Salehi, Kobra Velaei, & Nasser Samadi. (2020). The potential impact of trigonelline loaded micelles on Nrf2 suppression to overcome oxaliplatin resistance in colon cancer cells. Molecular Biology Reports. 47(8). 5817–5829. 31 indexed citations
12.
Ezzati, Maryam, Bahman Yousefi, Kobra Velaei, & Amin Safa. (2020). A review on anti-cancer properties of Quercetin in breast cancer. Life Sciences. 248. 117463–117463. 264 indexed citations breakdown →
13.
Valipour, Behnaz, Kobra Velaei, Ali Abedelahi, et al.. (2019). NK cells: An attractive candidate for cancer therapy. Journal of Cellular Physiology. 234(11). 19352–19365. 50 indexed citations
14.
Valipour, Behnaz, Ali Abedelahi, Kobra Velaei, et al.. (2019). Cord blood stem cell derived CD16+ NK cells eradicated acute lymphoblastic leukemia cells using with anti-CD47 antibody. Life Sciences. 242. 117223–117223. 24 indexed citations
15.
Ebrahimi‐Kalan, Abbas, et al.. (2018). Telomerase activity and telomere on stem progeny senescence. Biomedicine & Pharmacotherapy. 102. 9–17. 26 indexed citations
16.
Mehdizadeh, Amir, Mortaza Bonyadi, Masoud Darabi, et al.. (2017). Common chemotherapeutic agents modulate fatty acid distribution in human hepatocellular carcinoma and colorectal cancer cells. Bioimpacts. 7(1). 31–39. 20 indexed citations
17.
Shafiei‐Irannejad, Vahid, Nasser Samadi, Bahman Yousefi, et al.. (2017). Metformin enhances doxorubicin sensitivity via inhibition of doxorubicin efflux in P‐gp‐overexpressing MCF‐7 cells. Chemical Biology & Drug Design. 91(1). 269–276. 72 indexed citations
18.
Velaei, Kobra, et al.. (2016). Tumor microenvironment-mediated chemoresistance in breast cancer. The Breast. 30. 92–100. 114 indexed citations
19.
Velaei, Kobra, et al.. (2016). NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer. Breast Cancer. 24(4). 552–561. 20 indexed citations
20.
Khalilzadeh, Balal, Hojjatollah Nozad Charoudeh, Nasrin Shadjou, et al.. (2016). Ultrasensitive caspase-3 activity detection using an electrochemical biosensor engineered by gold nanoparticle functionalized MCM-41: Its application during stem cell differentiation. Sensors and Actuators B Chemical. 231. 561–575. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026